{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:25:31Z","timestamp":1792016731700,"version":"4.4.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1992,9,1]],"date-time":"1992-09-01T00:00:00Z","timestamp":715305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1992,9,1]],"date-time":"1992-09-01T00:00:00Z","timestamp":715305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm Gen Sect"],"published-print":{"date-parts":[[1992,9]]},"DOI":"10.1007\/bf02260903","type":"journal-article","created":{"date-parts":[[2005,11,23]],"date-time":"2005-11-23T02:50:12Z","timestamp":1132714212000},"page":"191-205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer type"],"prefix":"10.1007","volume":"4","author":[{"given":"E.","family":"Martignoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Blandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Petraglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Pacchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Bono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Nappi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[1992,9,1]]},"reference":[{"key":"BF02260903_CR1","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1192\/bjp.135.3.216","volume":"135","author":"R Adolfsson","year":"1979","unstructured":"Adolfsson R, Gottfries CG, Roos BE, Winblad B (1979) Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br J Psychiatry 135: 216\u2013223","journal-title":"Br J Psychiatry"},{"key":"BF02260903_CR2","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/0024-3205(80)90025-9","volume":"27","author":"R Adolfsson","year":"1980","unstructured":"Adolfsson R, Gottfries CG, Oreland L, Widberg A, Winblad B (1980) Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci 27: 1029\u20131034","journal-title":"Life Sci"},{"key":"BF02260903_CR3","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/306584a0","volume":"306","author":"TE Adrian","year":"1983","unstructured":"Adrian TE, Allen JM, Bloom SR, Ghatei MA, Rossor MN, Roberts GW, Crow TJ, Tatemoto K, Polak JM (1983) Neuropeptide Y distribution in human brain. Nature 306: 584\u2013586","journal-title":"Nature"},{"key":"BF02260903_CR4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0022-510X(84)90180-1","volume":"64","author":"JM Allen","year":"1984","unstructured":"Allen JM, Ferrier IN, Roberts GE, Gross AJ, Adrian TE, Crow TJ, Bloom SR (1984) Elevation of neuropeptide Y (NPY) in substantia innominata in Alzheimer type dementia. J Neurol Sci 64: 325\u2013331","journal-title":"J Neurol Sci"},{"key":"BF02260903_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0006-8993(85)91632-4","volume":"377","author":"JM Allen","year":"1985","unstructured":"Allen JM, Cross AJ, Crow TJ, Javoy-Agid F, Agid Y, Bloom SR (1985) Dissociation of neuropeptide Y and somatostatin in Parkinson's disease. Brain Res 377: 197\u2013200","journal-title":"Brain Res"},{"key":"BF02260903_CR6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000117347","volume":"30","author":"J Alom","year":"1990","unstructured":"Alom J, Galard R, Catalan R, Castellanos JM, Schwartz S, Tolosa E (1990) Cerebrospinal fluid neuropeptide Y in Alzheimer's disease. Eur Neurol 30: 207\u2013210","journal-title":"Eur Neurol"},{"key":"BF02260903_CR7","unstructured":"American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3 rd ed revised. Washington DC"},{"key":"BF02260903_CR8","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S0022-3565(25)26438-2","volume":"138","author":"AH Anton","year":"1962","unstructured":"Anton AH, Sayre DF (1962) A study of the factor affecting the aluminium oxide-trihydroxyindole procedure for the analysis of the catecholamines. J Pharmacol Exp Ther 138: 360\u2013375","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02260903_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0304-3940(84)90353-7","volume":"52","author":"H Arai","year":"1984","unstructured":"Arai H, Moroii T, Kosaka K (1984) Somatostatin and vasoactive intestinal polypeptide in postmortem brains from patients with Alzheimer's type dementia. Neurosci Lett 52: 73\u201378","journal-title":"Neurosci Lett"},{"key":"BF02260903_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1001\/archneur.1988.00520270043019","volume":"45","author":"JR Atack","year":"1988","unstructured":"Atack JR, Beal MF, May C, Kaye JA, Mazurek MF, Kay AD, Rapoport SI (1988) Cerebrospinal fluid somatostatin and neuropeptide Y. Concentrations in aging and dementia of the Alzheimer's type with and without extrapyramidal signs. Arch Neurol 45: 269\u2013274","journal-title":"Arch Neurol"},{"key":"BF02260903_CR11","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/ana.410200303","volume":"20","author":"MF Beal","year":"1986","unstructured":"Beal MF, Mazurek MF, Chattha GK, Svendsen CM, Bird ED, Martin JB (1986) Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease. Ann Neurol 20: 282\u2013288","journal-title":"Ann Neurol"},{"key":"BF02260903_CR12","first-page":"1247","volume":"i","author":"W Bondareff","year":"1981","unstructured":"Bondareff W, Mountjoy CQ, Roth M (1981) Selective loss of neurones of origin of adrenergic projection to cerebral cortex (nucleus locus caeruleus) in senile dementia. Lancet i: 1247\u20131249","journal-title":"Lancet"},{"key":"BF02260903_CR13","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/cne.902380404","volume":"238","author":"V Chan-Palay","year":"1985","unstructured":"Chan-Palay V, Lang W, Allen YS, Lang W, Haesler V, Polak JM (1985) Cortical neurons immunoreactive with antisera against neuropeptide Y are altered in Alzheimer's type dementia. J Comp Neurol 238: 390\u2013400","journal-title":"J Comp Neurol"},{"key":"BF02260903_CR14","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/cne.902480307","volume":"248","author":"V Chan-Palay","year":"1986","unstructured":"Chan-Palay V, Lang W, Haesler U, K\u00f6hler C, Yasargil G (1986) Distribution of altered hippocampal neurons and axons immunoreactive with antisera against neuropeptide Y in Alzheimer's type dementia. J Comp Neurol 248: 376\u2013394","journal-title":"J Comp Neurol"},{"key":"BF02260903_CR15","first-page":"18","volume":"1","author":"V Chan-Palay","year":"1990","unstructured":"Chan-Palay V, Jentsch B, Lang W, H\u00f6chli, Asan E (1990) Distribution of neuropeptide Y, c-terminal flanking peptide of NPY and galanin coexistence with catecholamine in the locus coeruleus of normal humans, Alzheimer's dementia and Parkinson's disease brains. Dementia 1: 18\u201331","journal-title":"Dementia"},{"key":"BF02260903_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0304-3940(84)90164-2","volume":"52","author":"BM Chronwall","year":"1984","unstructured":"Chronwall BM, Chase TN, O'Donohue TL (1984) Coexistence of neuropeptide Y and somatostatin in rat and in human cortical and rat hypothalamic neurons. Neurosci Lett 52: 213\u2013217","journal-title":"Neurosci Lett"},{"key":"BF02260903_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1136\/bmj.282.6258.93","volume":"1","author":"AJ Cross","year":"1981","unstructured":"Cross AJ, Crow TJ, Perry EK, Blessed G, Tomlinson BE (1981) Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease. Br Med J 1: 93\u201394","journal-title":"Br Med J"},{"key":"BF02260903_CR18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/288279a0","volume":"288","author":"P Davies","year":"1980","unstructured":"Davies P, Katzman R, Terry RD (1980) Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer's disease and Alzheimer senile dementia. Nature 288: 279\u2013280","journal-title":"Nature"},{"key":"BF02260903_CR19","first-page":"61","volume-title":"Neuropeptide Y","author":"BJ Everitt","year":"1989","unstructured":"Everitt BJ, H\u00f6kfelt T (1989) The coexistence of neuropeptide Y with other peptides and amines in the central nervous system. In: Mutt V, Fuxe K, H\u00f6kfelt T, Lundberg JM (eds) Neuropeptide Y. New York, Raven Press, pp 61\u201371"},{"key":"BF02260903_CR20","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/0306-4522(84)90036-8","volume":"11","author":"BJ Everitt","year":"1984","unstructured":"Everitt BJ, H\u00f6kfelt T, Terenius T, Tatemoto K, Mutt V, Goldstein M (1984) Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat. Neuroscience 11: 443\u2013462","journal-title":"Neuroscience"},{"key":"BF02260903_CR21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, Mc Hugh PR (1975) Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189\u2013198","journal-title":"J Psychiatr Res"},{"key":"BF02260903_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0304-3940(86)90015-7","volume":"63","author":"NL Forster","year":"1986","unstructured":"Forster NL, Tamminga CA, O'Donohue T, Tanimoto K, Bird ED, Chase TN (1986) Brain choline acetyltransferase activity and neuropeptide Y concentrations in Alzheimer's disease. Neurosci Lett 63: 71\u201375","journal-title":"Neurosci Lett"},{"key":"BF02260903_CR23","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/0028-3932(88)90057-7","volume":"26","author":"DM Freed","year":"1988","unstructured":"Freed DM, Corkin S, Growdon JH, Nissen MJ (1988) Selective attention in Alzheimer's disease: CSF correlates of behavioural impairments. Neuropsychologia 26: 895\u2013902","journal-title":"Neuropsychologia"},{"key":"BF02260903_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1748-1716.1983.tb07261.x","volume":"118","author":"K Fuxe","year":"1983","unstructured":"Fuxe K, Agnati LF, H\u00e4rfstrand A, Zini I, Tatemoto K, Merlo Pich E, H\u00f6kfelt T, Mutt V, Terenius L (1983) Central administration of neuropeptide Y induces hypotension bradypnea and EEG synchronization in the rat. Acta Physiol Scand 118: 189\u2013192","journal-title":"Acta Physiol Scand"},{"key":"BF02260903_CR25","first-page":"303","volume-title":"Progress in brain research","author":"K Fuxe","year":"1986","unstructured":"Fuxe K, Agnati LF, H\u00e4rfstrand A, Janson AM, Neumeyer A, Andersson K, Ruggeri M, Zoli M, Goldstein M (1986) Morphofunctional studies on the neuropeptide Y\/adrenaline costoring terminal systems in the dorsal cardiovascular region of the medulla oblongata. Focus on the receptor-receptor interactions in cotransmission. In: H\u00f6kfelt T, Fuxe K, Pernow B (eds) Progress in brain research, vol 68. Elsevier, Amsterdam, pp 303\u2013320"},{"key":"BF02260903_CR26","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/0197-4580(83)90002-7","volume":"4","author":"CG Gottfries","year":"1983","unstructured":"Gottfries CG, Adolfsson R, Aquilonius SM, Carlsson A, Eckernas SA, Nordberg A, Oreland L, Svennerholm L, Widberg A, Winblad B (1983) Biochemical changes in dementia disorders of Alzheimer type (AD\/SDAT). Neurobiol Aging 4: 262\u2013271","journal-title":"Neurobiol Aging"},{"key":"BF02260903_CR27","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","volume":"32","author":"MA Hamilton","year":"1959","unstructured":"Hamilton MA (1959) The assessment of anxiety states by rating. Br J Med Psychol 32: 50\u201355","journal-title":"Br J Med Psychol"},{"key":"BF02260903_CR28","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"MA Hamilton","year":"1960","unstructured":"Hamilton MA (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56\u201362","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02260903_CR29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1748-1716.1986.tb07966.x","volume":"128","author":"A H\u00e4rfstrand","year":"1986","unstructured":"H\u00e4rfstrand A, Fuxe K, Agnati LF, Benfenati F, Goldstein M (1986) Receptor autoradiographical evidence for high densities of 125 I-neuropeptide Y binding sites in the nucleus tractus solitarius of the normal male rat. Acta Physiol Scand 128: 195\u2013200","journal-title":"Acta Physiol Scand"},{"key":"BF02260903_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/BF01677422","volume":"75","author":"A H\u00e4rfstrand","year":"1989","unstructured":"H\u00e4rfstrand A, Fuxe K, Agnati LF and Fredholm B (1989) Reciprocal interactions between 2-adrenoreceptor agonist and neuropeptide Y binding sites in the nucleus tractus solitarius of the rat. J Neural Transm 75: 83\u201399","journal-title":"J Neural Transm"},{"key":"BF02260903_CR31","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1523\/JNEUROSCI.04-10-02497.1984","volume":"4","author":"SHC Hendry","year":"1984","unstructured":"Hendry SHC, Jones EG, Emson PC (1984) Morphology, distribution and synaptic relations of somatostatin and neuropeptide Y immunoreactive neurons in rat and monkey neocortex. J Neurosci 4: 2497\u20132517","journal-title":"J Neurosci"},{"key":"BF02260903_CR32","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17: 427\u2013442","journal-title":"Neurology"},{"key":"BF02260903_CR33","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0304-3940(83)90003-4","volume":"36","author":"T H\u00f6kfelt","year":"1983","unstructured":"H\u00f6kfelt T, Lundberg JM, Lagercrantz H, Tatemoto K, Mutt V, Lindberg J, Terenius L, Everitt BJ, Fuxe K, Agnati L, Goldstein M (1983) Occurence of neuropeptide Y (NPY)-like immunoreactivity in catecholamine neurons in the human medulla oblongata. Neurosci Lett 36: 217\u2013222","journal-title":"Neurosci Lett"},{"key":"BF02260903_CR34","first-page":"19","volume-title":"Advances in neurology","author":"O Hornykiewicz","year":"1986","unstructured":"Hornykiewicz O, Kish S (1986) Biochemical pathophysiology of Parkinson's disease. In: Yahr MD, Bergman KJ (eds) Advances in neurology, vol 45. Raven Press, New York, pp 19\u201334"},{"key":"BF02260903_CR35","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1212\/WNL.35.4.565","volume":"35","author":"HJ Hurst","year":"1985","unstructured":"Hurst HJ, Lewitt PA, Burns RS, Foster NL, Lovenberg W (1985) CSF dopamine-\u03b2-hydroxylase activity in Parkinson's disease. Neurology 35: 565\u2013568","journal-title":"Neurology"},{"key":"BF02260903_CR36","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/cne.902440310","volume":"244","author":"C K\u00f6hler","year":"1986","unstructured":"K\u00f6hler C, Eriksson L, Davies S, Chan-Palay V (1986) Neuropeptide Y innervation of the hippocampal region in the rat and monkey brain. J Comp Neurol 244: 284\u2013400","journal-title":"J Comp Neurol"},{"key":"BF02260903_CR37","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1212\/WNL.29.9_Part_1.1253","volume":"2","author":"PR Lesser","year":"1979","unstructured":"Lesser PR, Fahn S, Snider SR, Cote LJ, Isgreen WP, Barett RE (1979) Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy. Neurology 2: 1253\u20131260","journal-title":"Neurology"},{"key":"BF02260903_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0304-3940(83)90401-9","volume":"42","author":"JM Lundberg","year":"1983","unstructured":"Lundberg JM, Terenius T, H\u00f6kfelt T Goldstein M (1983) High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neurosci Lett 42: 167\u2013172","journal-title":"Neurosci Lett"},{"key":"BF02260903_CR39","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1136\/jnnp.46.10.905","volume":"46","author":"JJ Mann","year":"1983","unstructured":"Mann JJ, Stanley M, Kaplan RD, Sweeney J, Neophytides A (1983) Central catecholamine metabolism in vivo and the cognitive and motor deficits in Parkinson's disease. J Neurol Neurosurg Psychiatry 46: 905\u2013910","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02260903_CR40","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34: 939\u2013944","journal-title":"Neurology"},{"key":"BF02260903_CR41","first-page":"182","volume":"1","author":"GV Melzi d'Eril","year":"1986","unstructured":"Melzi d'Eril GV (1986) A rapid and simple method for determining catecholamines in human plasma and cerebrospinal fluid using high-performance liquid chromatography with electrochemical detection. Funct Neurol 1: 182\u2013190","journal-title":"Funct Neurol"},{"issue":"Suppl","key":"BF02260903_CR42","first-page":"57","volume":"30","author":"L Minthon","year":"1990","unstructured":"Minthon L, Edvinsson L, Ekman R, Gustafson L (1990a) Neuropeptide levels in Alzheimer's disease and dementia with frontotemporal degeneration. J Neural Transm [Suppl] 30: 57\u201367","journal-title":"J Neural Transm"},{"key":"BF02260903_CR43","first-page":"262","volume":"1","author":"L Minthon","year":"1990","unstructured":"Minthon L, Edvinsson L, Ekman R, Gustafson L (1990b) Cerebrospinal fluid neuropeptide Y-like immunoreactive levels in dementia of Alzheimer type and dementia with frontotemporal degeneration of non-Alzheimer type. Dementia 1: 262\u2013266","journal-title":"Dementia"},{"key":"BF02260903_CR44","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1212\/WNL.34.7.979","volume":"34","author":"RJ Polinsky","year":"1984","unstructured":"Polinsky RJ, Jimerson DC, Kopin IJ (1984) Chronic autonomic failure: CSF and plasma 3-methoxy-4-hydroxyphenylglycol. Neurology 34: 979\u2013983","journal-title":"Neurology"},{"key":"BF02260903_CR45","doi-asserted-by":"crossref","unstructured":"Quinn N (1989) Multiple system atrophy: the nature of the beast. J Neurol Neurosurg Psychiatry [Special Suppl]: 78\u201389","DOI":"10.1136\/jnnp.52.Suppl.78"},{"key":"BF02260903_CR46","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1001\/archpsyc.1984.01790150033006","volume":"41","author":"MA Raskind","year":"1984","unstructured":"Raskind MA, Peskind ER, Halter JB, Jimerson DC (1984) Norepinephrine and MHPG levels in CSF and plasma in Alzheimer's disease. Arch Gen Psychiatry 41: 343\u2013346","journal-title":"Arch Gen Psychiatry"},{"key":"BF02260903_CR47","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0197-4580(88)80061-7","volume":"9","author":"J Reinikaininen","year":"1988","unstructured":"Reinikaininen J, Palj\u00e4rvi L, Halonen T, Malminen O, Kosma VM, Laakso M, Riekkinen PJ (1988) Dopaminergic system and monoamine oxidase-B activity in Alzheimer's disease. Neurobiol Aging 9: 245\u2013252","journal-title":"Neurobiol Aging"},{"key":"BF02260903_CR48","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1176\/ajp.139.9.1136","volume":"139","author":"B Reisberg","year":"1982","unstructured":"Reisberg B, Ferris SH, De Leon MJ, Crook T (1982) The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 139: 1136\u20131139","journal-title":"Am J Psychiatry"},{"key":"BF02260903_CR49","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/BF01252019","volume":"41","author":"P Riederer","year":"1977","unstructured":"Riederer P, Birkmayer W, Seemann D, Wuketich S (1977) Brain noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's syndrome. J Neural Transm 41: 241\u2013251","journal-title":"J Neural Transm"},{"key":"BF02260903_CR50","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1001\/archneur.1973.00490200055007","volume":"28","author":"UK Rinne","year":"1973","unstructured":"Rinne UK, Sonninen V (1973) Brain catecholamines and their metabolites in Parkinsonian patients. Arch Neurol 28: 107\u2013110","journal-title":"Arch Neurol"},{"key":"BF02260903_CR51","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/clinchem\/33.6.844","volume":"33","author":"V Rizzo","year":"1987","unstructured":"Rizzo V, Melzi d'Eril GV (1987) Determination of free 3-methoxy-4-hydroxyphenylethy-leneglycol in plasma and cerebrospinal fluid by liquid chromatography with coulometric detection. Clin Chem 33: 844\u2013845","journal-title":"Clin Chem"},{"key":"BF02260903_CR52","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0304-3940(80)90177-9","volume":"20","author":"MN Rossor","year":"1980","unstructured":"Rossor MN, Emson PC, Mountjoy CQ, Roth M, Iversen LL (1980) Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type. Neurosci Lett 20: 373\u2013377","journal-title":"Neurosci Lett"},{"key":"BF02260903_CR53","first-page":"376","volume":"28","author":"AE Rubenstein","year":"1978","unstructured":"Rubenstein AE, Yahr MD, Mytilineou C (1978) Peripheral adrenergic hypersensitivity in orthostatic hypotension: the effect of denervation versus decentralization. Neurology 28: 376","journal-title":"Neurology"},{"key":"BF02260903_CR54","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1523\/JNEUROSCI.05-07-01729.1985","volume":"5","author":"CA Sasek","year":"1985","unstructured":"Sasek CA, Elde RP (1985) Distribution of neuropeptide Y-like immunoreactivity and its relationship to FMRF-amide-like immunoreactivity in the sixth lumbar and first sacral spinal cord segments of the rat. J Neurosci 5: 1729\u20131739","journal-title":"J Neurosci"},{"key":"BF02260903_CR55","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0022-510X(84)90193-X","volume":"63","author":"H Soininen","year":"1984","unstructured":"Soininen H, Joskkonen JT, Reinikainen KJ, Halonew PO, Riekkinen PJ (1984) Reduced cholinesterase activity and somatostatin like immunoreactivity in the cerebrospinal fluid of patients with dementia of the Alzheimer type. J Neurol Sci 63: 167\u2013172","journal-title":"J Neurol Sci"},{"key":"BF02260903_CR56","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0022-510X(79)90073-X","volume":"43","author":"E Spokes","year":"1979","unstructured":"Spokes E, Bannister R, Oppenheimer DR (1979) Multiple system atrophy with autonomic failure. Clinical, histological and neurochemical observations on four cases. J Neurol Sci 43: 59\u201382","journal-title":"J Neurol Sci"},{"key":"BF02260903_CR57","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1001\/archneur.1984.04050210084021","volume":"41","author":"Y Stern","year":"1984","unstructured":"Stern Y, Mayeux R, Cote L (1984) Reaction time and vigilance in Parkinson's disease. Possible role of altered norepinephrine metabolism. Arch Neurol 41: 1086\u20131089","journal-title":"Arch Neurol"},{"key":"BF02260903_CR58","doi-asserted-by":"publisher","first-page":"5485","DOI":"10.1073\/pnas.79.18.5485","volume":"79","author":"K Tatemoto","year":"1982","unstructured":"Tatemoto K (1982) Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci 79: 5485\u20135489","journal-title":"Proc Natl Acad Sci"},{"key":"BF02260903_CR59","first-page":"47","volume":"3","author":"PF Teychenne","year":"1977","unstructured":"Teychenne PF, Lake CR, Ziegler MG, Plotkin C, Wood JH, Calne DB (1977) Central and peripheral deficiency of norepinephrine in Parkinson's disease and the effects of L-dopa therapy. Neurosci Abs 3: 47","journal-title":"Neurosci Abs"},{"key":"BF02260903_CR60","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/B978-0-409-95184-4.50010-2","volume-title":"The catecholamines in psychiatric and neurologic disorders","author":"PF Teychenne","year":"1985","unstructured":"Teychenne PF, Feuerstein G, Lake CR, Ziegler MG (1985) Central catecholamine systems: interactions with neurotransmitters in normal subjects and in patients with selected neurologic diseases. In: Lake CR, Ziegler MG (eds) The catecholamines in psychiatric and neurologic disorders. Butterworth, Stoneham, pp 91\u2013119"},{"key":"BF02260903_CR61","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/mds.870040508","volume":"4","author":"PJ Whitehouse","year":"1989","unstructured":"Whitehouse PJ (1989) Parkinson's disease and Alzheimer's disease: new neurochemical parallels. Mov Disord 4: 57\u201362","journal-title":"Mov Disord"},{"key":"BF02260903_CR62","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0022-3956(88)90030-1","volume":"22","author":"E Widerl\u00f6w","year":"1988","unstructured":"Widerl\u00f6w E, Lindstr\u00f6m LH, Wahlestedt C, Ekman R (1988) Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively. J Psychiatr Res 22: 69\u201379","journal-title":"J Psychiatr Res"},{"key":"BF02260903_CR63","first-page":"170","volume-title":"Research progress in Parkinson's disease","author":"A Williams","year":"1981","unstructured":"Williams A (1981) CSF biochemical studies on some extrapyramidal diseases. In: Rose FC, Capildeo R (eds) Research progress in Parkinson's disease. Pitman, London, pp 170\u2013180"},{"key":"BF02260903_CR64","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/0024-3205(82)90099-6","volume":"31","author":"PL Wood","year":"1982","unstructured":"Wood PL Etienne P, Lal S, Gauthier S, Cajal S, Nair NPV (1982) Reduced lumbar CSF somatostatin levels in Alzheimer's disease. Life Sci 31: 2073\u20132079","journal-title":"Life Sci"},{"key":"BF02260903_CR65","first-page":"346","volume":"115","author":"TL Yaksh","year":"1990","unstructured":"Yaksh TL, Carmichael SW, Stoddard SL, Tyce G, Kelly PJ, Lucas D, Van Heerden JA, Ahlskog JE, Byer DE (1990) Measurement of lumbar CSF levels of met-enkephalin, encrypted met-enkephalin, and neuropeptide Y in normal patients and in patients with Parkinson's disease before and after autologous transplantation of adrenal medulla into the caudate nucleus. J Lab Clin Med 115: 346\u2013351","journal-title":"J Lab Clin Med"},{"key":"BF02260903_CR66","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1056\/NEJM197702102960601","volume":"296","author":"MG Ziegler","year":"1977","unstructured":"Ziegler MG, Lake CR, Kopin IJ (1977) The sympathetic nervous system defect in primary orthostatic hypotension. N Engl J Med 296: 293\u2013297","journal-title":"N Engl J Med"}],"container-title":["Journal of Neural Transmission - Parkinson's Disease and Dementia Section"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02260903.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02260903\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02260903","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02260903.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T05:02:48Z","timestamp":1750827768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02260903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,9]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1992,9]]}},"alternative-id":["BF02260903"],"URL":"https:\/\/doi.org\/10.1007\/bf02260903","relation":{},"ISSN":["0936-3076"],"issn-type":[{"value":"0936-3076","type":"print"}],"subject":[],"published":{"date-parts":[[1992,9]]},"assertion":[{"value":"13 May 1991","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 1991","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 1992","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}